| Literature DB >> 31271523 |
Josef Heusinger1, Heika Hildebrandt1, Robert-Benjamin Illing1.
Abstract
INTRODUCTION: Cochlear ablation causing sensory deafferentation (SD) of the cochlear nucleus triggers complex re-arrangements in the cellular and molecular communication networks of the adult mammalian central auditory system. Participation of the extracellular matrix (ECM) in these processes is not well understood.Entities:
Keywords: Gap43 protein; auditory pathways; chondroitin sulfate proteoglycans; matrix metalloproteinase 2; regeneration
Mesh:
Substances:
Year: 2019 PMID: 31271523 PMCID: PMC6710208 DOI: 10.1002/brb3.1353
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Antibodies used in the study
| Antigen | Description of immunogen | Source, host species, catalog no., RRID | Dilution (DAB/FL/EM) |
|---|---|---|---|
| Primary antibodies | |||
| Aggrecan | Mouse aggrecan, amino acids 1177–1326 | Millipore, rabbit polyclonal, AB1031, AB_90460 | 1:2,000/−/− |
| Gad65 | Purified rat brain glutamic acid decarboxylase, 65 kDa isoform | Millipore, mouse monoclonal, MAB351, AB_2263126 | 1:2,000/1:1,000/1:500 |
| Gap43 | Purified rat brain growth‐associated protein 43 | Millipore, mouse monoclonal, MAB347, AB_94881 | 1:5,000/1:1,000/1:1,000 |
| GFAP | Glial fibrillary acidic protein from pig spinal cord | Sigma‐Aldrich, mouse monoclonal, G3893, AB_477010 | –/1:5,000/– |
| HuC/HuD | Human HuC/HuD neuronal protein | Molecular Probes, mouse monoclonal, A−21271, AB_221448 | –/1:125/– |
| MMP2 | Human MMP2, amino acids 1–76 | Santa Cruz, rabbit polyclonal, sc−10736, AB_2250826 | –/1:40/1:20 |
| Neurocan | Mouse/rat neurocan, full‐length form and proteolytic fragments | R&D Systems, sheep polyclonal, AF5800, AB_2149717 | 1:1,000/1:500/1:500 |
| vGluT1 | Synthetic peptide from rat vesicular glutamate transporter 1 | Millipore, guinea pig polyclonal, AB5905, AB_2301751 | 1:5,000/1:1,000/– |
| Secondary antibodies | |||
| Guinea pig IgG biotinylated | Vector, goat, BA‐7000, AB_2336132 | 1:200 | |
| Mouse IgG biotinylated | Vector, horse, BA‐2001, AB_2336180 | 1:200 | |
| Rabbit IgG biotinylated | Vector, goat, BA‐1000, AB_2313606 | 1:200 | |
| Sheep IgG biotinylated | Vector, rabbit, BA‐6000, AB_2336217 | 1:200 | |
| Mouse IgG Alexa 405 | Abcam, donkey, ab175659, (no RRID) | 1:200 | |
| Sheep IgG Alexa 488 | Molecular Probes, donkey, A‐11015, AB_141362 | 1:200 | |
| Guinea pig IgG Cy3 | Millipore, donkey, AP193C, AB_92669 | 1:200 | |
| Mouse IgG Cy3 | Millipore, donkey, AP192C, AB_92642 | 1:200 | |
| Rabbit IgG Cy3 | Millipore, donkey, AP182C, AB_92588 | 1:200 | |
| Mouse FAB Nanogold | Nanoprobes, goat, 2002, AB_2637031 | 1:100 | |
| Rabbit FAB Nanogold | Nanoprobes, goat, 2004, (no RRID) | 1:100 | |
Statistical data of grayscale analysis in VCN
| Ncan | Agg | Gap43 | Gad65 | vGluT1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VCN: staining ratio i/c | ANOVA overall | W (DFn,DFd) | 23.29 (4, 15.91) | 14.07 (4, 25.14) | 27.04 (4, 19.85) | 22.35 (4, 13.40) | 20.16 (4, 12.60) | ||||||
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||
| No. of animals | mean ± | Co | 7 | 1.021 ± 0.007 | 6 | 0.986 ± 0.025 | 7 | 0.987 ± 0.007 | 5 | 0.993 ± 0.015 | 5 | 0.991 ± 0.016 | |
| POD1 | 9 | 1.283 ± 0.081 | 10 | 1.112 ± 0.050 | 12 | 1.025 ± 0.009 | 9 | 1.074 ± 0.025 | 8 | 1.041 ± 0.023 | |||
| POD3 | 9 | 3.072 ± 0.336 | 10 | 1.427 ± 0.061 | 12 | 1.499 ± 0.139 | 6 | 1.202 ± 0.014 | 6 | 0.802 ± 0.022 | |||
| POD7 | 12 | 1.471 ± 0.075 | 12 | 1.196 ± 0.039 | 12 | 1.306 ± 0.036 | 7 | 1.123 ± 0.012 | 5 | 0.838 ± 0.043 | |||
| POD14 | 7 | 1.490 ± 0.099 | 7 | 1.303 ± 0.085 | 7 | 1.237 ± 0.045 | 6 | 1.154 ± 0.051 | 3 | 0.842 ± 0.019 | |||
|
| Co vs. POD1 | 0.089 | 0.299 | 0.035 | 0.137 | 0,548 | |||||||
| Co vs. POD3 | 0.003 | <0.001 | 0.031 | <0.001 | <0.001 | ||||||||
| Co vs. POD7 | 0.001 | 0.003 | <0.001 | 0.008 | 0,127 | ||||||||
| Co vs. POD14 | 0.024 | 0.067 | 0.011 | 0.150 | 0,012 | ||||||||
| POD1 vs POD3 | 0.005 | 0.008 | 0.049 | 0.008 | <0.001 | ||||||||
| POD1 vs. POD7 | 0.613 | 0.849 | <0.001 | 0.804 | 0.042 | ||||||||
| POD1 vs. POD14 | 0.674 | 0.480 | 0.018 | 0.801 | 0.001 | ||||||||
| POD3 vs. POD7 | 0.010 | 0.049 | 0.840 | 0.119 | 0.994 | ||||||||
| POD3 vs. POD14 | 0.013 | 0.912 | 0.559 | 0.972 | 0.8173 | ||||||||
| POD7 vs. POD14 | >0.999 | 0.920 | 0.906 | 0.999 | >0.9999 | ||||||||
| VCN: across‐brain comparison of gray values on right with contralateral sides | ANOVA overall | W (DFn,DFd) | 0.047 (4, 18.64) | 2.057 (4, 17.71) | 2.967 (4, 17.98) | 2.485 (4, 12.80) | 0.675 (4, 8.368) | ||||||
|
| 0.995 | 0.130 | 0.048 | 0.096 | 0.627 | ||||||||
| No. of animals | mean ± | Co | 7 | 183.7 ± 4.471 | 6 | 145.5 ± 13.92 | 7 | 214.3 ± 6.697 | 5 | 205 ± 5.148 | 5 | 195.6 ± 9.464 | |
| POD1 | 9 | 180.8 ± 10.06 | 10 | 111.3 ± 9.685 | 12 | 220.3 ± 2.301 | 9 | 213.4 ± 3.342 | 8 | 181.8 ± 7.345 | |||
| POD3 | 9 | 183.8 ± 5.193 | 10 | 121.2 ± 8.081 | 12 | 218.4 ± 1.967 | 6 | 211.5 ± 2.110 | 6 | 177.5 ± 4.145 | |||
| POD7 | 12 | 184.7 ± 6.999 | 12 | 136.4 ± 6.420 | 12 | 225.2 ± 1.014 | 7 | 219.1 ± 1.981 | 5 | 185.4 ± 12.25 | |||
| POD14 | 7 | 186.1 ± 7.056 | 7 | 137.9 ± 4.949 | 7 | 224.3 ± 2.447 | 6 | 216.5 ± 2.460 | 3 | 184.3 ± 9.387 | |||
|
| Co vs. POD1 | >0.999 | 0.438 | 0.983 | 0.813 | 0.916 | |||||||
| Co vs. POD3 | >0.999 | 0.742 | 0.999 | 0.897 | 0.607 | ||||||||
| Co vs. POD7 | >0.999 | 0.999 | 0.687 | 0.280 | 0.997 | ||||||||
| Co vs. POD14 | >0.999 | >0.999 | 0.801 | 0.470 | 0.980 | ||||||||
| POD1 vs. POD3 | >0.999 | 0.994 | 0.999 | >0.999 | >0.999 | ||||||||
| POD1 vs. POD7 | >0.999 | 0.334 | 0.474 | 0.771 | >0.999 | ||||||||
| POD1 vs. POD14 | >0.999 | 0.224 | 0.917 | 0.996 | >0.999 | ||||||||
| POD3 vs. POD7 | >0.999 | 0.769 | 0.067 | 0.174 | 0.998 | ||||||||
| POD3 vs. POD14 | >0.999 | 0.583 | 0.513 | 0.723 | 0.993 | ||||||||
| POD7 vs. POD14 | >0.999 | >0.999 | >0.999 | 0.988 | >0.999 | ||||||||
The upper half of the table shows statistic data for the ipsilateral‐to‐contralateral ratio in VCN for Ncan, Agg, Gap43, Gad65, and vGluT1. The lower half shows data of gray value comparisons in the right/contralateral VCN. Welch's ANOVA was used to determine whether means among groups differed significantly. Dunnett's T3 post hoc tests were applied. For each group, number of animals, mean, and SEM are indicated.
Abbreviations: W, W ratio of the Welch's ANOVA; DFn, degrees of freedom for numerator; DFd, degrees of freedom for denominator.
Significance levels are indicated as ***p < 0.001, **p < 0.01, or *p < 0.05.
Statistical data of grayscale analysis in CIC
| Ncan | Agg | Gap43 | Gad65 | vGluT1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CIC: staining ratio | ANOVA overall | W (DFn,DFd) | 6.158 (4, 18.41) | 4.308 (4, 18.67) | 4.018 (4, 19.59) | 19.48 (4, 12.16) | 6.025 (4, 8.435) | ||||||
|
| 0.003 | 0.012 | 0.015 | <0.001 | 0.014 | ||||||||
| No. of animals | mean ± | Co | 6 | 1.000 ± 0.022 | 6 | 0.973 ± 0.020 | 7 | 0.986 ± 0.025 | 5 | 1.001 ± 0.007 | 5 | 0.984 ± 0.012 | |
| POD1 | 10 | 1.278 ± 0.068 | 10 | 1.116 ± 0.030 | 12 | 1.166 ± 0.036 | 9 | 1.059 ± 0.016 | 8 | 1.05 ± 0.009 | |||
| POD3 | 8 | 1.097 ± 0.047 | 10 | 1.046 ± 0.027 | 12 | 1.048 ± 0.019 | 6 | 0.861 ± 0.023 | 6 | 1.013 ± 0.023 | |||
| POD7 | 12 | 0.994 ± 0.015 | 11 | 0.980 ± 0.024 | 12 | 1.024 ± 0.016 | 7 | 0.882 ± 0.023 | 5 | 0.976 ± 0.035 | |||
| POD14 | 6 | 0.947 ± 0.020 | 7 | 1.022 ± 0.022 | 7 | 1.036 ± 0.027 | 5 | 0.900 ± 0.020 | 3 | 0.973 ± 0.017 | |||
|
| Co vs. POD1 | 0.022 | 0.013 | 0.008 | 0.074 | 0.013 | |||||||
| Co vs. POD3 | 0.520 | 0.351 | 0.455 | 0.009 | 0.933 | ||||||||
| Co vs. POD7 | >0.999 | >0.999 | 0.871 | 0.013 | >0.999 | ||||||||
| Co vs. POD14 | 0.563 | 0.669 | 0.826 | 0.036 | 0.999 | ||||||||
| POD1 vs. POD3 | 0.319 | 0.593 | 0.089 | <0.001 | 0.772 | ||||||||
| POD1 vs. POD7 | 0.019 | 0.023 | 0.025 | 0.001 | 0.465 | ||||||||
| POD1 vs. POD14 | 0.006 | 0.197 | 0.090 | 0.002 | 0.130 | ||||||||
| POD3 vs. POD7 | 0.410 | 0.552 | 0.976 | 0.998 | 0.980 | ||||||||
| POD3 vs. POD14 | 0.124 | 0.998 | >0.999 | 0.877 | 0.816 | ||||||||
| POD7 vs. POD14 | 0.525 | 0.877 | >0.999 | 0.999 | >0.999 | ||||||||
| CIC: across‐brain comparison of gray values on left with ipsilateral sides | ANOVA overall |
| 1.853 (4, 15.90) | 1.711 (4, 16.54) | 1.768 (4, 18.94) | 3.734 (4, 11.75) | 0.087 (4, 9.568) | ||||||
|
| 0.168 | 0.195 | 0.177 | 0.035 | 0.985 | ||||||||
| No. of animals | mean ± | Co | 6 | 153.7 ± 6.515 | 6 | 91.7 ± 15.08 | 7 | 159.1 ± 12.85 | 5 | 145.6 ± 11.84 | 5 | 182.6 ± 12.29 | |
| POD1 | 10 | 177.7 ± 11.45 | 10 | 90.3 ± 10.98 | 12 | 137.3 ± 10.56 | 9 | 172.6 ± 11.88 | 8 | 186 ± 11.08 | |||
| POD3 | 8 | 166 ± 7.201 | 10 | 90.7 ± 5.762 | 12 | 127.4 ± 6.057 | 6 | 134 ± 9.022 | 6 | 181.5 ± 6.941 | |||
| POD7 | 12 | 176.8 ± 5.390 | 11 | 112.4 ± 6.234 | 12 | 148.2 ± 7.771 | 7 | 171 ± 4.884 | 5 | 190.6 ± 13.39 | |||
| POD14 | 6 | 164 ± 14.29 | 7 | 94.6 ± 10.79 | 7 | 130.1 ± 12.78 | 5 | 147.2 ± 10.43 | 3 | 183.3 ± 7.535 | |||
|
| Co vs. POD1 | 0.542 | >0.999 | 0.854 | 0.683 | >0.999 | |||||||
| Co vs. POD3 | 0.875 | >0.999 | 0.337 | 0.991 | >0.999 | ||||||||
| Co vs. POD7 | 0.144 | 0.864 | 0.995 | 0.499 | >0.999 | ||||||||
| Co vs. POD14 | 0.997 | >0.999 | 0.687 | >0.999 | >0.999 | ||||||||
| POD1 vs. POD3 | 0.987 | >0.999 | 0.993 | 0.177 | >0.999 | ||||||||
| POD1 vs. POD7 | >0.999 | 0.590 | 0.991 | >0.999 | >0.999 | ||||||||
| POD1 vs. POD14 | 0.995 | >0.999 | >0.999 | 0.685 | >0.999 | ||||||||
| POD3 vs. POD7 | 0.909 | 0.162 | 0.351 | 0.054 | 0.998 | ||||||||
| POD3 vs. POD14 | >0.999 | >0.999 | >0.999 | 0.968 | >0.999 | ||||||||
| POD7 vs. POD14 | 0.984 | 0.791 | 0.899 | 0.446 | >0.999 | ||||||||
The upper half of the table shows statistic data for the contralateral‐to‐ipsilateral ratio in CIC for Ncan, Agg, Gap43, Gad65, and vGluT1. The lower half shows data of gray value comparisons in the left/ipsilateral CIC. Welch's ANOVA was used to determine whether means among groups differed significantly. Dunnett's T3 post hoc tests were applied. For each group, number of animals, mean, and SEM are indicated.
Abbreviations: W, W ratio of the Welch's ANOVA; DFn, degrees of freedom for numerator; DFd, degrees of freedom for denominator.
Significance levels are indicated as ***p < 0.001, **p < 0.01, or *p < 0.05.
Figure 1Ncan expression following SD. Ncan is shown in CIC by POD1 (a) and in VCN by POD3 (b). Insets show higher magnification of Ncan(+) PNNs (arrowheads). SD side is marked by incision (x). Neuronal cell bodies are indicated by asterisks. LSO, lateral superior olive; n7, facial nerve; n8, vestibulocochlear nerve; aq, cerebral aqueduct; IV, fourth ventricle. Scale bar for a, b: 200 µm, scale bar for insets: 20 µm
Figure 2Time course of Ncan expression in VCN. Ncan transiently rose in ipsilateral VCN with a maximum around POD3 (c), followed by a decline toward POD7 (d) and POD14 (e). Higher magnification (a′–e′) reveals Ncan(+) PNNs (arrowheads) by POD3, POD7, and POD14 but not in controls. Neuronal cell bodies are indicated by asterisks. Scale bar for a–e: 200 µm, scale bar for a′–e′: 20 µm. (f) Analysis of ipsilateral(i)‐to‐contralateral(c) staining ratio, indicating a significant rise of Ncan by POD3 and its subsequent decline. Means are connected by line. Dashed line indicates symmetry between ipsilateral and contralateral sides
Figure 3Agg and Gap43 in VCN. Agg(+) PNNs were present in controls (a, arrowheads). Their staining intensity rose by POD3 (b) and decreased toward POD7 (c). Gap43 immunoreactivity was hardly present in untreated adult brains (d) but rose toward POD3 (e). By POD3 and POD7, Gap43 mostly stained presynaptic boutons (arrows). Neuronal cell bodies are indicated by asterisks. Scale bar for a–f: 20 µm. Staining ratio of Agg (g) rose toward POD3 and declined thereafter. Gap43 staining ratio (h) was increased by POD3 and remained high by POD14
Figure 4Ncan and synaptic markers in VCN. Changes in Ncan expression were accompanied by loss of glutamatergic synaptic boutons (a–c, arrows). Inset shows double labeling of Ncan and the neuronal marker HuC/HuD in VCN by POD3, with Ncan(+) PNNs exclusively covering neurons. GABAergic boutons (arrows) gained in staining intensity by POD3 (e) and POD7 (f). Most GABAergic boutons seemed to be embedded in Ncan(+) PNNs (arrowheads) by POD3 (e). Gap43(+) profiles (arrows) were often found close but outside the Ncan(+) PNNs by POD3 (h), but in contact to cell bodies by POD7 (i). Neuronal cell bodies are indicated by asterisks. Scale bar for a–i: 20 µm; scale bar for inset: 20 µm. In the quantification of vGluT1 (j), staining ratio dropped by POD3 and remained low. Ratio of Gad65 (k) rose by POD3
Figure 5Fluorescence triple labeling of Ncan, matrix metalloproteinase‐2 (MMP2), and glial fibrillary acidic protein (GFAP) in VCN. By POD3, Ncan(+) PNNs (b, arrowheads) were touched by numerous activated GFAP(+) astrocytic processes. Inset shows high magnification of Ncan inside GFAP‐stained astrocyte. Concurrently to the decrease in Ncan toward POD7, MMP2 has risen in thick astrocytic fibers (c'''), while it was mainly found in neuronal somata and the neuropil in controls (a''') and by POD3 (b'''). Neuronal cell bodies are indicated by asterisks. Scale bar for a–c: 20 µm; scale bar for inset: 5 µm
Figure 6Ultrastructure of the deafferented VCN. GABAergic boutons (a, black dots, green profiles) and Gap43(+) boutons (b, black dots, red profiles) with DAB‐stained Ncan (darkened regions) are shown on or near neuronal somata by POD3, with Gap43(+) profiles laying in varying distances to the neuron (yellow profiles). Unstained synaptic boutons are marked as blue profiles. By POD4, Gap43(+) presynaptic profiles are found in different maturational states: a Gap43‐bearing fiber in a region darkly stained by Ncan (c), two immature Gap43(+) synapses distant to a neuron, separated from it by Ncan (d), a Gap43(+) growth cone (e) failing to show an active zone growing into the Ncan(+) PNN, and a mature Gap43(+) bouton (f) attached to a neuronal soma, forming a synaptic contact with the neuron. An astrocyte (af, purple profiles), residing in direct vicinity to a synaptic bouton, was found to be enriched with Ncan (dark staining). (g) Staining for Ncan (dark staining) and MMP2 (black dots) at POD4. MMP2 was found in astrocytes (purple) and neurons (yellow). In the neuropil, MMP2 colocated strongly with Ncan (asterisks). Postsynaptic densities marked by arrowheads; a, axon; af, astrocytic filaments; n, nucleus. Scale bar for a, b: 5 µm; scale bar for c, d, f: 2 µm; scale bar for e, g: 1 µm
Figure 7Effects in CIC. Graphs (a–e) show analysis of contralateral(c)‐to‐ipsilateral(i) staining ratio of mean gray values in CIC for all survival groups and 5 molecular markers. Means are connected by line. Dashed lines indicate symmetry between ipsilateral and contralateral sides. Ncan (a), Agg (b), Gap43 (c), and vGluT1 (d) all showed transient peaks of ratios by POD1. Only Gad65 (e) failed to show an effect by POD1 but decreased by POD3 to remain low. In fluorescence double labeling at POD1 in the CIC (f–i), Ncan staining dominated contralaterally and was mostly localized in PNNs (g, f, arrowheads). Staining differences for the synaptic markers vGluT1 and Gap43 were too subtle to be discernible in selected photographs but emerged by sampling from DAB‐stained sections (c, d). Synaptic boutons are indicated by arrows. Neuronal cell bodies are indicated by asterisk. Scale bar for f–i: 20 µm
Figure 8Ncan staining in dorsal cochlear nucleus (DCN), lateral superior olive (LSO), and medial geniculate body (MGB) by POD3. In DCN (a, b), a rise of Ncan expression pattern was reminiscent to that in VCN but weaker. In LSO (c, d, outlined by dashed line), we found scattered Ncan(+) PNNs (arrowheads) in controls and at all survival times, with no differences between hemispheres. In MGB (e, f) Ncan staining was absent from either side in any experimental group. Neuronal cell bodies are indicated by asterisk. MGBv, ventral part of the medial geniculate body; MGBd, dorsal part of the medial geniculate body; MGBm, medial part of the medial geniculate body; MSO, medial superior olive. Scale bars for a–d: 200 µm; scale bars for insets: 20 µm